Apollo Commercial Real Estate (ARI) Q4 2025 earnings review
Portfolio Sale Announced Following Dividend Recovery
ARI delivered a solid Q4 operational performance, with Distributable Earnings of $0.26 per share covering the $0.25 dividend—a critical recovery after shortfall concerns earlier in the year. However, the headline news was buried in the presentation's subsequent events: ARI has entered a definitive agreement to sell its entire loan portfolio to Athene Holding Ltd. at 99.7% of loan commitments. This transaction effectively caps the investment thesis, shifting the narrative from a 'going concern' turnaround to a liquidation/exit event at a valuation near par.
🐂 Bull Case
The agreement to sell the loan portfolio at 99.7% of commitments is a strong outcome, validating the carrying value of the assets. With Book Value at $12.14, a sale near par implies minimal equity erosion for shareholders upon liquidation.
Athene's willingness to acquire the entire book validates ARI's pivot to Europe (43% of portfolio) and Residential assets (26%). The aggressive origination of $4.4B in 2025 created a refreshed, high-quality portfolio that attracted a buyer.
🐻 Bear Case
With a definitive sale agreement in place, the stock effectively becomes an arbitrage play. The potential for future earnings growth or multiple expansion is removed; investors are now waiting for deal closure and capital return.
While the asset sale price is 99.7%, the net return to equity holders will be reduced by transaction fees, wind-down costs, and the settlement of liabilities (debt-to-equity is ~3.7x). The final cash distribution may drift lower than current Book Value.
⚖️ Verdict: ⚪
Neutral. The company successfully stabilized operations and covered its dividend, but the announcement of the portfolio sale to Athene converts the stock into a merger-arb situation. The operational turnaround is now secondary to the transaction mechanics.
Key Themes
The Athene Portfolio Sale
In a major strategic shift, ARI announced a definitive agreement to sell its entire loan portfolio to Athene Holding Ltd. The purchase price is based on 99.7% of total loan commitments. This follows a year where ARI aggressively grew its book by $1.7B, effectively dressing the company for sale. This transaction resolves lingering concerns about legacy asset monetization by offloading the entire book en masse.
Europe as the Growth Engine
ARI's pivot to Europe has been the primary driver of its 2025 expansion. Europe now accounts for 43% of the portfolio (UK 30%, Other Europe 13%), providing diversification away from the troubled U.S. office market. In Q4 alone, 100% of originations were floating rate senior mortgages, heavily skewed toward these regions.
Aggressive Capital Deployment
2025 was a year of massive reloading. ARI committed $4.4B to new loans (vs. $1.9B in 2024), significantly outpacing repayments of $2.9B. This net portfolio growth drove the Total Loan Portfolio to $8.8B, generating the interest income necessary to restore dividend coverage in Q4.
Office Exposure Remains
Despite the diversification efforts, Office remains a significant 24% of the portfolio ($2.1B). While the company touts that its largest office commitment is 100% leased to a credit tenant, the sector remains a drag on valuation multiples. The Athene sale effectively solves this for shareholders by transferring this risk at a defined price.
Specific Credit Issue in Chicago
In Q4, ARI recorded a $3.0 million Specific CECL allowance on a hotel loan in Chicago. While small relative to the $8.8B portfolio, it highlights that credit friction persists even as the macro environment stabilizes.
Legacy Asset Resolution
Progress continues on legacy headaches. The 111 West 57th Street loan saw six contracts closed in Q4 ($109M net proceeds), paying down ARI's loan. The Brooklyn Multifamily REO ($638M asset) has commenced move-ins with 56% of market units leased. These resolutions likely helped facilitate the clean sale of the portfolio.
Other KPIs
Stable. Up from $0.23 in Q3 (prior to adjustments) and flat vs Q2. Importantly, this covers the $0.25 dividend, fulfilling management's promise to cover the payout by year-end.
Stable. Slight decline from $12.18 in Q3 and $12.34 in FY24, largely due to CECL allowances and depreciation. This figure serves as the baseline for estimating the final distribution from the Athene sale.
Decelerating. Down from 7.7% in Q3 and 8.1% in FY24, reflecting tighter spreads on new high-quality originations (Europe/Residential) and falling benchmark rates.
Guidance
The company did not provide standard earnings guidance due to the pending sale of the portfolio to Athene. The 'guidance' is effectively the transaction price: 99.7% of the loan book. Investors should model returns based on this liquidation value minus transaction costs and debt repayment.
Key Questions
Net Proceeds to Equity
With the sale price at 99.7% of loan commitments, what is the estimated net cash distribution per share after extinguishing the $6.2B in secured debt and covering transaction fees?
Closing Timeline
What are the closing conditions and expected timeline for the Athene transaction? Are there regulatory hurdles given the cross-border nature (UK/Europe) of the portfolio?
Unfunded Commitments Treatment
The sale price refers to '99.7% of total loan commitments.' Does this premium apply to the unfunded portion of commitments, or is it strictly on the funded balance at closing?